It is known that increased levels of homocysteine in plasma have been associated with various diseases. Current studies show that homocysteine is a new risk factor for the development of osteoporosis. Fragility fractures are associated with increased morbidity, mortality and...
Open access
Research Article10.9734/ARRB/2017/36176
The purpose of the current review is to bring up to date some studies and data about the effects of hypoglycemic oral drugs in combination with DPP-4 inhibitors. As the medicine and pharmaceutical industry are revolutionary in type 2 diabetes protocols, scientists made a close re...
Open access
Research Article10.9734/jpri/2022/v34i20A35820